Research output per year
Research output per year
Fingerprint
Dive into the research topics where John Manning is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 152 Citations
- 6 h-Index
- 10 Article
-
Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model
Blake, S., Shaabani, N., Eubanks, L. M., Maruyama, J., Manning, J. T., Beutler, N., Paessler, S., Ji, H., Teijaro, J. R. & Janda, K. D., Aug 13 2021, In: ACS Infectious Diseases. 7, 8, p. 2229-2237 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A single mutation (V64G) within the ring domain of Z attenuates junin virus
Hallam, S. J., Manning, J. T., Maruyama, J., Seregin, A., Huang, C., Walker, D. H., de la Torre, J. C. & Paessler, S., Sep 2020, In: PLoS neglected tropical diseases. 14, 9, p. 1-15 15 p., e0008555.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
The Glycoprotein of the Live-Attenuated Junin Virus Vaccine Strain Induces Endoplasmic Reticulum Stress and Forms Aggregates prior to Degradation in the Lysosome
Manning, J. T., Yun, N. E., Seregin, A. V., Koma, T., Sattler, R. A., Ezeomah, C., Huang, C., de la Torre, J. C. & Paessler, S., Mar 31 2020, In: Journal of virology. 94, 8Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs
Maruyama, J., Mateer, E. J., Manning, J. T., Sattler, R., Seregin, A. V., Bukreyeva, N., Jones, F. R., Balint, J. P., Gabitzsch, E. S., Huang, C. & Paessler, S., Oct 23 2019, In: Vaccine. 37, 45, p. 6824-6831 8 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Lethal infection of Lassa virus isolated from a human clinical sample in outbred guinea pigs without adaptation
Maruyama, J., Manning, J. T., Mateer, E. J., Sattler, R., Bukreyeva, N., Huang, C. & Paessler, S., 2019, In: mSphere. 4, 5, e00428-19.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations
Press / Media
-
Sorrento Therapeutics And ViralClear Enter Into Agreement To Explore Combination Antibody Plus Antiviral Therapy Against COVID-19
Slobodan Paessler, Cheng Huang & John Manning
9/30/20
19 items of Media coverage
Press/Media: Expert Comment
-
SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19
Slobodan Paessler, Cheng Huang & John Manning
9/30/20
21 items of Media coverage
Press/Media: Expert Comment
-
ViralClear Expands Ongoing Phase 2 Trial Size for its Oral Anti-Viral for the Treatment of COVID-19, Expands Trial Locations and Appoints Contract Manufacturing Organization to Manufacture Phase 3 Supplies of Merimepodib Oral Solution
Slobodan Paessler, Cheng Huang & John Manning
9/22/20
12 items of Media coverage
Press/Media: Expert Comment
-
BioSig Technologies Adopts Stockholder Rights Agreement
Slobodan Paessler, Cheng Huang & John Manning
7/16/20 → 7/19/20
2 items of Media coverage
Press/Media: Expert Comment
-
BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit Nasdaq:BSGM
Slobodan Paessler, Cheng Huang & John Manning
7/17/20 → 7/18/20
27 items of Media coverage
Press/Media: Expert Comment